Aminosaccharides
Sigma Aldrich Fine Chemicals Biosciences Hyaluronic acid sodium salt from Streptococcus equi mol wt 2,000,000-2,400,000 | 9067-32-7 | MFCD01773053 | 50MG
Hyaluronic acid sodium salt from Streptococcus equi mol wt 2,000,000-2,400,000 | 9067-32-7 | MFCD01773053 | 50MG
Medchemexpress LLC D(+)-Galactosamine hydrochloride | 1772-03-8 | 99.9% | 215.63 | 1 G
D(+)-Galactosamine hydrochloride is an established experimental toxin known to primarily cause liver injury by generating free radicals and depleting UTP nucleotides. It also induces renal dysfunction, often leading to renal failure associated with end-stage liver damage. This compound can be used to induce hepatitis models, mimicking viral hepatitis by causing lipid peroxidation and cell membrane deterioration.
- Induces apoptosis and necrosis in primary cultures of rat hepatocytes.
- Causes caspase-3 activation and DNA fragmentation.
- Used as an animal model for fulminant hepatic failure.
- Induces acute liver failure in mice when co-administered with Lipopolysaccharide.
Apexbio Technology LLC N-acetyl D-galactosamine 1811-31-0 100mg
N-acetyl D-galactosamine (CAS 1811-31-0) is an endogenous amino sugar that serves as a structural component in glycoproteins and glycolipids It functions as a fundamental building block in the biosynthesis of O-linked glycoproteins participating in post-translational modification and influencing cell signaling adhesion and molecular recognition processes Due to its role in the formation of brain heteropolysaccharides N-acetyl D-galactosamine is frequently utilized in studies investigating glycosylation neural development and carbohydrate-mediated cellular interactions within biomedical research
Sigma Aldrich Fine Chemicals Biosciences D-(+)-Galactosamine hydrochloride | 1772-03-8 | MFCD00135830 | 5 g
D-(+)-Galactosamine hydrochloride | Purity: ≥99% | Mol Wt: 215.63 | 1772-03-8 | MFCD00135830 | 5 g
Medchemexpress LLC D(+)-Galactosamine (hydrochloride) | 1772-03-8 | 99.9% | 215.63 | 200 MG
D(+)-Galactosamine hydrochloride is an established experimental toxin that primarily causes liver injury by generating free radicals and depleting UTP nucleotides. It also induces renal dysfunction, with renal failure often associated with the end-stage of liver damage. Lipopolysaccharide/D(+)-Galactosamine-induced acute liver injury is a known animal model of fulminant hepatic failure.
- Induces apoptosis and necrosis in primary cultures of rat hepatocytes.
- Induces caspase-3 activation and DNA fragmentation.
- Used to induce hepatitis models similar to viral hepatitis.
- Induces lipid peroxidation and deterioration of cell membranes.
- Can be used in rat models (Wistar) to study liver damage.
- Can be used in mouse models (C57BL/6J) for acute liver failure induction.
Apexbio Technology LLC D-+-Galactosamine 1772-03-8 500mg
D-plus-Galactosamine is a small-molecule agent used to induce hepatocellular injury for research applications It functions by disrupting the intracellular metabolism of uridine diphosphate (UDP)-sugars consequently impairing glycoprotein and glycolipid biosynthesis and triggering metabolic disturbances in hepatocytes D-plus-Galactosamine exerts its biological activity primarily through the induction of hepatocellular damage inflammatory responses and apoptotic signaling cascades via UDP-sugar metabolic disruption Based on these pharmacological properties D-plus-Galactosamine holds research potential in modeling acute hepatic injury studying hepatitis pathogenesis and liver dysfunction investigating inflammation-mediated hepatocyte death mechanisms and evaluating hepatoprotective strategies
Sigma Aldrich Fine Chemicals Biosciences D-(+)-Galactosamine hydrochloride >=99% | 1772-03-8 | MFCD00135830 | 10MG
D-(+)-Galactosamine hydrochloride >=99% | Purity: >=99% | Mol Wt: 215.63 | 1772-03-8 | MFCD00135830 | 10MG
Sigma Aldrich Fine Chemicals Biosciences Hyaluronic acid sodium salt from Streptococcus equi mol wt 30,000-50,000 | 9067-32-7 | MFCD01773053 | 10MG
Hyaluronic acid sodium salt from Streptococcus equi mol wt 30,000-50,000 | 9067-32-7 | MFCD01773053 | 10MG
Sigma Aldrich Fine Chemicals Biosciences D-(+)-Galactosamine hydrochloride >=99% | 1772-03-8 | MFCD00135830 | 25G
D-(+)-Galactosamine hydrochloride >=99% | Purity: >=99% | Mol Wt: 215.63 | 1772-03-8 | MFCD00135830 | 25G
![eMolecules 14215-68-0 | N-Acetyl-D-galactosamine | Chem-Impex | MFCD00065372 | 221.209 | C8H15NO6 | 0.000 | CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O | 1g | 112755741](https://assets.fishersci.com/TFS-Assets/CCG/product-images/501714173.jpg-250.jpg)
eMolecules 14215-68-0 | N-Acetyl-D-galactosamine | Chem-Impex | MFCD00065372 | 221.209 | C8H15NO6 | 0.000 | CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O | 1g | 112755741
N-Acetyl-D-galactosamine | Chem-Impex | 14215-68-0 | MFCD00065372 | 221.209 | C8H15NO6 | 0.000 | CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O | 1g | 112755741
Spiramycin, 90%
CAS: 8025-81-8 Molecular Formula: C43H74N2O14 Molecular Weight (g/mol): 843.065 MDL Number: MFCD01314545 InChI Key: ACTOXUHEUCPTEW-ZOTSFZJCSA-N Synonym: spiramycin PubChem CID: 131674974 IUPAC Name: 2-[(4R,5S,6S,7R,9R,10R,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxa SMILES: CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C
MilliporeSigma™ Erythromycin, ≥85%, Calbiochem™,
CAS: 114-07-8 Molecular Formula: C37H67NO13 Molecular Weight (g/mol): 733.94 MDL Number: MFCD00084654 InChI Key: ULGZDMOVFRHVEP-RWJQBGPGSA-N Synonym: erythromycin,erythromycin a,e-mycin,abomacetin,erythrocin,erythromycinum,erymax,erythromycine,eritromicina,emgel PubChem CID: 12560 ChEBI: CHEBI:42355 IUPAC Name: (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
Phenyl N-Acetyl-alpha-D-glucosaminide, TCI America™
CAS: 10139-04-5 Molecular Formula: C14H19NO6 Molecular Weight (g/mol): 297.307 MDL Number: MFCD00067651 InChI Key: ZUJDLWWYFIZERS-PDWCTOEPSA-N Synonym: Phenyl 2-Acetamido-2-deoxy-alpha-D-glucopyranoside PubChem CID: 133655432 IUPAC Name: N-[(2S,3S,4S,5S,6S)-4,5-dihydroxy-6-(hydroxymethyl)-2-phenoxyoxan-3-yl]acetamide SMILES: CC(=O)NC1C(C(C(OC1OC2=CC=CC=C2)CO)O)O
4-Methoxyphenyl 2-Amino-3,6-di-O-benzyl-2-deoxy-beta-D-glucopyranoside, TCI America™
CAS: 1272755-07-3 Molecular Formula: C27H31NO6 Molecular Weight (g/mol): 465.546 InChI Key: DFPWFVXGRBQWGQ-RFNQJFSXSA-N PubChem CID: 44629780 IUPAC Name: (2R,3S,4R,5R,6S)-5-amino-6-(4-methoxyphenoxy)-4-phenylmethoxy-2-(phenylmethoxymethyl)oxan-3-ol SMILES: COC1=CC=C(C=C1)OC2C(C(C(C(O2)COCC3=CC=CC=C3)O)OCC4=CC=CC=C4)N